NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000001471

Registered date:01/12/2008

Comparison of ursodeoxycholic acid 900 mg/day and 1200 mg/day for chronic hepatitis C patients

Basic Information

Recruitment status Recruiting
Health condition(s) or Problem(s) studiedchronic hepatitis C
Date of first enrollment2008/10/01
Target sample size40
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)UDCA 900 mg/day UDCA 1200 mg/day

Outcome(s)

Primary Outcomedecrease in serum ALT levels
Secondary Outcomeadverse events

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteriadecompensated cirrhosis under anti-viral therapy complete biliary obstruction pregnancy

Related Information

Contact

public contact
Name Haruhiko YOSHIDA
Address Hongo 7-3-1, Bunkyo, Tokyo Japan
Telephone 03-3815-5411
E-mail yoshida-2im@h.u-tokyo.ac.jp
Affiliation The University of Tokyo Gastroenterology
scientific contact
Name Haruhiko YOSHIDA
Address Hongo 7-3-1, Bunkyo, Tokyo Japan
Telephone 03-3815-5411
E-mail
Affiliation The University of Tokyo Department of Gastroenterology